Abstract
Background: Common childhood neuropsychiatric disorders are treated with multiple categories of psycho-active agents. Adverse side effects of psychotropic pharmacotherapeutics range from expected neuro-psychiatric changes to allergic reactions and immunologic abnormalities.
Objective: This review focuses on the immune system effects of common categories of medications used to treat neuro-psychiatric and behavioral disorders.
Method: Narrative review of literature using PubMed database up to May 10, 2017.
Results: Multiple neuro- and psycho-tropic medication classes are found to influence the function of the immune system in various ways, both in the direction of immune suppression and immune stimulation.
Conclusion: Immunologic activity of these medications in the frame-work of now wellestablished role of inflammation in neuro-psychiatric diseases should continue to be defined. At the same time, clinicians are advised to pay attention to potentially detrimental immune suppression that may be associated with some of these medications, and consider iatrogenic etiology in patients presenting with undue susceptibility to infection.
Keywords: Inflammation, immune, psychotropic, psychopharmacology, psychiatric, immunodeficiency.
Current Psychopharmacology
Title:Immunologic Effects of Psychotropic Pharmaco-Therapeutics
Volume: 7
Author(s): Andrey Leonov*, Donald E. Greydanus and H.C. Athens
Affiliation:
- Western Michigan University, Homer Stryker M.D. School of Medicine, Kalamazoo, Michigan, MI 49008-1284,United States
Keywords: Inflammation, immune, psychotropic, psychopharmacology, psychiatric, immunodeficiency.
Abstract: Background: Common childhood neuropsychiatric disorders are treated with multiple categories of psycho-active agents. Adverse side effects of psychotropic pharmacotherapeutics range from expected neuro-psychiatric changes to allergic reactions and immunologic abnormalities.
Objective: This review focuses on the immune system effects of common categories of medications used to treat neuro-psychiatric and behavioral disorders.
Method: Narrative review of literature using PubMed database up to May 10, 2017.
Results: Multiple neuro- and psycho-tropic medication classes are found to influence the function of the immune system in various ways, both in the direction of immune suppression and immune stimulation.
Conclusion: Immunologic activity of these medications in the frame-work of now wellestablished role of inflammation in neuro-psychiatric diseases should continue to be defined. At the same time, clinicians are advised to pay attention to potentially detrimental immune suppression that may be associated with some of these medications, and consider iatrogenic etiology in patients presenting with undue susceptibility to infection.
Export Options
About this article
Cite this article as:
Leonov Andrey *, Greydanus E. Donald and Athens H.C. , Immunologic Effects of Psychotropic Pharmaco-Therapeutics, Current Psychopharmacology 2018; 7 (1) . https://dx.doi.org/10.2174/2211556006666171019155320
DOI https://dx.doi.org/10.2174/2211556006666171019155320 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Matrix Metalloproteinase Dependent Cleavage of Cell Adhesion Molecules in the Pathogenesis of CNS Dysfunction with HIV and Methamphetamine
Current HIV Research Coffee and Depression: A Short Review of Literature
Current Pharmaceutical Design Medicinal Chemistry Approaches of Controlling Gastrointestinal Side Effects of Non-Steroidal Anti-Inflammatory Drugs. Endogenous Protective Mechanisms and Drug Design
Medicinal Chemistry A Peptide Based Pro-Drug Ameliorates Amyloid-β Induced Neuronal Apoptosis in In Vitro SH-SY5Y Cells
Current Alzheimer Research Conference Report
CNS & Neurological Disorders - Drug Targets Difficulties in Describing Allergic Disease Modulation by Pre-, Pro- and Synbiotics
Current Pharmaceutical Design Ontogenetic Variation of the Human Genome
Current Genomics Senescence of the Brain: Focus on Cognitive Kinases
Current Pharmaceutical Design Impact of Jugular Vein Valve Function on Cerebral Venous Haemodynamics
Current Neurovascular Research Treating Cancer in Older and Oldest Old Patients
Current Pharmaceutical Design Editorial (Thematic Issue: Dopamine in the Brain)
Central Nervous System Agents in Medicinal Chemistry Anti-tumor Effects of Curcuminoids in Glioblastoma Multiforme: An Updated Literature Review
Current Medicinal Chemistry Adeno-Associated Viral Vectors for Retinal Gene Transfer and Treatment of Retinal Diseases
Current Gene Therapy Research Highlights BAY 1436032: A Novel Pan-mutant IDH1 Inhibitor Extends Survival of Mice with Experimental Brain Tumors
CNS & Neurological Disorders - Drug Targets Professionalism and Adolescent Psychiatry in the Digital Age
Adolescent Psychiatry Stress as a Pathophysiological Factor in Functional Somatic Syndromes
Current Psychiatry Reviews Non-Enzymatic Protein Acetylation by 7-Acetoxy-4-Methylcoumarin: Implications in Protein Biochemistry
Protein & Peptide Letters Aβ Oligomers Induce Glutamate Release from Hippocampal Neurons
Current Alzheimer Research Polymeric Nanoparticles of FMISO: Are Nano-Radiopharmaceuticals Better Than Conventional Ones?
Current Radiopharmaceuticals Do Folate, Vitamins B<sub>6</sub> and B<sub>12</sub> Play a Role in the Pathogenesis of Migraine? The Role of Pharmacoepigenomics
CNS & Neurological Disorders - Drug Targets